Second generation patents in pharmaceutical innovation:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Abschlussarbeit Buch |
| Sprache: | English |
| Veröffentlicht: |
Baden-Baden
Nomos
2014
|
| Ausgabe: | 1. ed. |
| Schriftenreihe: | MIPLC Studies
19 |
| Schlagworte: | |
| Online-Zugang: | kostenfrei Inhaltsverzeichnis |
| Beschreibung: | 354 S. |
| ISBN: | 9783848708741 |
| DOI: | 10.5771/9783845250861 |
Internformat
MARC
| LEADER | 00000nam a22000008cb4500 | ||
|---|---|---|---|
| 001 | BV041731244 | ||
| 003 | DE-604 | ||
| 005 | 20240528 | ||
| 007 | t | ||
| 008 | 140312s2014 gw m||| 00||| eng d | ||
| 015 | |a 14,N07 |2 dnb | ||
| 016 | 7 | |a 1047120224 |2 DE-101 | |
| 020 | |a 9783848708741 |c Pb. : ca. EUR 89.00 (DE), ca. EUR 91.50 (AT), ca. sfr 125.00 (freier Pr.) |9 978-3-8487-0874-1 | ||
| 024 | 3 | |a 9783848708741 | |
| 035 | |a (OCoLC)870542522 | ||
| 035 | |a (DE-599)DNB1047120224 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-BW | ||
| 049 | |a DE-M382 |a DE-384 |a DE-19 |a DE-29T |a DE-355 |a DE-473 |a DE-859 |a DE-521 |a DE-634 |a DE-1051 |a DE-706 |a DE-1046 |a DE-860 | ||
| 082 | 0 | |a 340 | |
| 082 | 0 | |a 346.0486 |2 22/ger | |
| 084 | |a PU 1547 |0 (DE-625)139927: |2 rvk | ||
| 084 | |a 340 |2 sdnb | ||
| 100 | 1 | |a Ahn, Hyewon |e Verfasser |0 (DE-588)1052960936 |4 aut | |
| 245 | 1 | 0 | |a Second generation patents in pharmaceutical innovation |c Hyewon Ahn |
| 250 | |a 1. ed. | ||
| 264 | 1 | |a Baden-Baden |b Nomos |c 2014 | |
| 300 | |a 354 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a MIPLC Studies |v 19 | |
| 502 | |b Dissertation |c Universität Augsburg |d 2013 | ||
| 650 | 0 | 7 | |a Patentrecht |0 (DE-588)4044884-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Medizinprodukt |0 (DE-588)4024018-6 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | 2 | |a Medizinprodukt |0 (DE-588)4024018-6 |D s |
| 689 | 0 | 3 | |a Patentrecht |0 (DE-588)4044884-8 |D s |
| 689 | 0 | |5 DE-604 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-3-8452-5086-1 |
| 830 | 0 | |a MIPLC Studies |v 19 |w (DE-604)BV035044599 |9 19 | |
| 856 | 4 | 1 | |u http://doi.org/10.5771/9783845250861 |x Verlag |z kostenfrei |3 Volltext |
| 856 | 4 | 2 | |m SWB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027178023&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 912 | |a ZDB-18-NEA | ||
Datensatz im Suchindex
| _version_ | 1805074139842609152 |
|---|---|
| adam_text |
THE ATJANTIC
.;~
ILI
ER
.
C
H
E
ERED
ME
ON,
*
I
LO\E
AND
A
PPRECIATE
HYEWON
AHN
I
NHALT
SV
E
R
ZEIC
HNIS
TEN
I
N
G
TO
M
Y
ACA
DONGHI
AND
DR.
JOERG
KIN
D PROOFI'EADING
;RATEFU
L
10
MY
OFFICE
.
~1AGD
A
L
E
N
A
KOLASA,
~
,~
G
AN
D FUN
FILLED EN
-
.,
8
JOUME
Y
.
I
OW
E
TH
E
M
L
I
ST
OF
A
BBRE
V
IA
TION
S
15
J.
IN
T
R
O
DU
CTI
O
21
A.
O
V
E
RVIEW
21
B.
O
UTLINE
OF
THE
DI
SSE
RTATION
25
C.
SC
O
PE
O
F
TH
E DI
SS
ERTATION
25
TI.
P
HA
RM
AC
E
U
TI
C
AL
INV
E
NTION
S
,
LNN
O
V
A
TIO
NS
&
P
RO
DUCTS
28
A.
C
UMUJATIVE NATURE
OF
INV
E
NTIONS
28
1.
B
A
SI
C
AND
S
ECOND
GEN
E
RA
TIO
N
INVENTIONS
29
A)
L
M
P
R
OVEMENT
IN
VE
NTIONS 30
B)
S
E
LECTION INV
E
N
TIO
N
S
30
B.
INVENTIONS
AND
INNOVATIONS IN
PHANNA
C
E
UTICAL
FJELD
32
1.
INVENTIO
N
S AND
PATENT
S
IN
P
HA
RM
A
C
E
U
T
ICAL
FJ
ELD
32
A)
PRO
DU
CT
I
NV
ENTION AND
THE
ABSO
L
UTE
CHARACTER
OF
ITS
PROTECTION
33
B)
HIERARCHY
OF
PH
ATM
ACEUTICAL
P
A
T
ENTS
34
2.
INNOVATIONS
IN
PHANN
A
CE
UTICAL
FJELD
36
A)
INVE
NTI
ON
V. INNO
VA
TION
36
B)
NM
E
S
A
S
T
BE
CORE
OF
PHAR
M
A
CEUT
I
CAL
INNOVATION
37
C.
SEC
O
ND
GEN
ER
A
TION INVENTIONS
AND
PATENTS IN
PHARMACEUT
IC
A
L
S
38
1
.
P
R
ODUCT
INVENTIONS
AN
D
PATENTS
39
A)
S
PE
CIES
SELECTION
INVENTIONS
39
B)
O
P
TICAL
ISOM
E
R
S
43
C) CRYSTALLINE
FONM
46
D)
M
E
TABO
U
TE
S
AND
PRODRUGS
47
E)
ESTER
S
A
ND
SALT
S
49
F)
D
O
SA
GE
FONNS
49
G)
C
OMBINATIONS
OF
ACTI
VE
IN
G
R
E
DICNTS
50
7
L
I/HAI
/SI
'E
RZE
I
C
H
17
I
5
2.
U
SE
I
NV
E
NTION
S
50
A)
NE
W
U
S
E
LN
E
W METHOD
OF
TREA
T
M
E
NT
50
B)
DO
SA
GE REGIME
52
3
.
P
RO
CE
SS
IN
VE
NTIONS
52
A)
P
R
OC
ESS
52
B)
LNT
E
LMEDIAT
ES
53
D.
P
H
ARMACELLLICAL PRODUCTS IN THE MARKET
53
1.
NE
W MEDICAL
E
N
TITIES,
NEW
MOLECULAR ENTITIES
54
2.
SIMIL
A
R
OR
EQLLIVAL
ENT
"
M
E
-
T
O
O
"
PRO
DUCTS
54
3
.
S
E
COND GENERATION
PROD
UC
TS
5
6
4.
GE
N
E
RI
C
DRUG
S
57
E. S
UMMARY 58
W
.
SP
EC
I
FICJTL
ES
IN PHA
R
MACEU
T
IC
ALS
A
N
D
R
EC
E
NT
D
EVELOPM
ENT
S 59
A.
ILLLLOVATING
A
ND INVENTING IN PHALMACELLTICAL INDU
S
TRY
59
1.
SP
EC
IFI
C
IUE
ES I
N
TH
E
DRUG
DE
VELOPMENT
PROCES
S
59
A)
H
IG
H
L
Y
RE
G
ULATED
INDUSTRY 59
B)
R&
D
-
A
CO
S
TLY A
ND LENGTHY
ROAD TO A
ME
D
ICINE
60
C)
U
NCE
R
TAINTI
ES
IN POST-INV
E
NTION
D
E
V
E
L
OPME
N
T
64
(1)
SC
IENTIFIC UNCERTAIN
TY
:
U
NPR
E
DICT
ABI
LITY
OF
S
U
B
STA
N
CES
64
(
2
)
R
EGU
L
A
T
O
R
Y
A
N
D
M
A
RK
ET
UN
CE
RTA
INTI
E
S
65
D
)
I
NF
OL
MATION
RICH
CH
ERNI
CA
LS
66
2.
SPE
CIFI
CI
T
I
ES
IN THE
MARKET
FOR
PHA
NNACE
UT
ICALS
67
A)
IMITA
TI
ON WITH
NEGLIGI
BL
E
CO
ST
A
ND
MU
C
H R
EDUCE
D
L
IS
K
67
B)
PR
E
SCRI
PTIO
N
B
A
S
ED
PURCH
A
SE:
A
D
ISC01
1NECTION
B
E
TW
EE
N
CHOO
SE
R
S
AN
D
P
AYE
RS 68
C)
IN
F
O
NNA
TION ASYRNME
TR
Y
AND
HIGH LOY
ALTY
1
0
A
M
EDIC
IN
E 6
D
)
P
RI
CING
7
0
3.
SPECIFICITIES
OFTHE
P
ATE
NT
PR
OTECTION
FOR
P
HALMACEUTICALS
72
A)
PA
TE
NT
P
RO
TECTION FOR
IND
U
SL
R
IA
L
L
EC
HN
OLOGIES
72
B
)
PATENT
P
RO
T
ECL
ION
IN
TH
E
P
HALMACEUTI
CA
I
IND
U
STRY
74
B
.
CHALLENGES AND
OV
ERC
O
MIN
G
EFF
ORTS
1.
DE
C
REA
SE
D
R&
D
PR
ODUCTIVITY
2
.
DEARTH
OFNEW
MED
I
CA
L
E
NTITIES
A)
SI
GNI
FIC
A
NCE
OF
NMES
B)
DE
CRE
A
SE
D
N
U
M
BER
OF
NMES
80
8
INHALTSVERZEICHNIS
50
C)
P
OT
E
NTIAL REASONS FOR
TH
E D
EC
R
E
A
SE
83
50
(1)
D
ECREASE
IN SOLVAB
LE
S
C
I
E
NTIFI
C
P
ROB
L
EMS
83
52
(2) STRINGENT
SAFETY
REGUL
ATIO
NS
84
52
(3)
PRO
BLEM
OF
OV
ER
-DISCL
O
S
UR
E
84
52
(4)
E
ARLY
AND
NUMEROUS
A
BAN
DONMENTS
OF
POTENTIAL
53
CALLD
IDA
TES
85
3
.
PATEN
T
CL
I
FFS
OF
BLOCKBU
STER
M
EDICATIONS 86
53
4
.
FREQUENT
MERG
E
R
AN
D
AC
Q
UISITIONS
(
M&AS
) AND IN-LICENS
IN
G
86
54
5.
DRASTI
C
INCRE
ASE
OF
SE
COND
GENER
ATION
INVENTIONS
88
54
A) LIFE CYELE
MANAGEM
E
N
T OR EV
E
RG
RE
E
NING
89
56
B)
DRASTIC
INC
R
E
ASE
OF
THIS ACTIVI
TY SU
PPORTED
BY THE
NUMBER
57
OF
SECO
ND
GE
N
ERATION PAT
E
NTS
91
58
C.
SUMMARY
93
:J
RECENT
N
.
ST
AN
D
ARDS OF
PA
TE
N
TABLL
IT
Y
FOR
59
P
HARM
ACEUTI
CAL
SE
L
EC
TION
IN
VE
N
TIONS
95
59
A.
NO
VELTY
AND
ANTICIPATION
96
59
1.
LNT
RODUCTION 96
59
2.
E
XAMINATION
OF
NOVELTY
98
60
3.
INHE
RENT
ANTICIPATION
AND
E
N
ABLEMENT
103
64
4.
N
OVELTY
OF
SEL
EC
TI
ON
INVENTIONS
106
TAN
CE
S
64
A)
SP
EC
IES
S
E
LECTION INVENTIONS 106
65
B)
OP
T
ICAL ISOMERS 117
66
C) CRYSTALLINE FORMS 127
67
D) METABOLITE 130
D
R
I
SK
67
5.
ANALYSIS
AND CONCLUSION 133
N B
ETWEE
N
68
B.
INVE
NTIVE STEP
/ N
O
N-OBV
IO
US
N
ESS
134
A
ME
D
ICIN
E
69
1.
I
NVENTIVE
STE
P IN
PATE
NT
A
BILITY REQUIREMENTS 135
70
2
.
E
XA
MINATION
OF
INVENTIV
E STE
P 136
U
TICALS
72
3.
INV
E
NTIVE
STE
P
REQUI
R
E
MENT FOR
SELECTION
INVENTIONS
144
72
A) SPECI
ES
S
E
LECTI
ON INVENTI
ON
1
44
RRY
74
B)
OPTIC
AL ISOM
ERS
1
50
C)
C
RYSTA
LLI
NE FORMS 1
5
7
76
D)
META
BOLITES 164
78
4.
ANALY
S
IS AND CON
CLU
SI
ON
164
80
80
C.
D
IS
CLOSUR
E RE
QU
IR
EME
NT 167
80
1.
WR
ITTEN DESCL
'
IPTION REQUIREMENT
168
9
INHAIFSLE
R::.
DCLLLLI'
2.
ENABLE
ME
N
T
RCQ
UI
R
ERN
EN
T 1
7
1
A
)
ENAB
L
EM
E
NT REQUIREMENT
1
71
B)
E
NA
B
LE
MENT R
E
Q
UI
RE
MENTS IN THE
P
ATENT
LAW
175
(
1
)
E
NABLEM
EN
T AS A
RE
QUIREM
ENT
FOR ANTIEIPATION 1
7
5
(2)
B
ASIE
S
IMILARI
TY
O
FTHE
TWO ENABL
E
MENT
REQUIREMENTS 1
7
6
(3)
D
IFFE
R
E
N
E
ES
BETW
EE
N THE
T\VO
EN
ABLE
MENT
REQU
IR
ERN
E
NTS 177
3.
D
ISCL
OSURE REQUIREMENT
OF
SELEETION INVENTIONS
17
8
A)
SPE
EI
ES
SE
L
E
ETION INVENTION 1
7
8
B)
OP
T
IC
AL
ISOM
ERS
17
9
E)
C
RYS
TALL
TNE
FORMS 1
8
0
D. CONC1USION 1
8
0
V.
IM
PLFCAT
ION
S
OF
TH
E
P
A
T
EN
TAB
I
LF
TY
RE
QUIREMEN
T
S
ON
INNOV
ATIO
N
AN
D C
OMPETI
TI
ON
IN
T
H
E
PH
ARMACEU
TIC
AL IND
US
T
RY
18
4
A
.
C
ON
E
EM
S
A
B
OUT LOWERED PATENTABILITY
1
85
1.
G
ENERAL
EON
C
ERN
S
ABOUT LOW
ERE
D
PA
TE
NT
ABILITY
18
A)
S
UP
E
R
FLUOU
S
SE
C
OND
GENERATION
P
AT
E
NTS
1
85
B
)
LNEREA
SE
D
P
ATEN
T
EXC
LUSIVITI
ES
AND AMPLI
FI
E
D
UNEERTA
I
N
T
I
ES
T
H
EREOF
1
8
7
E)
ENEOURA
G
E
D W
AS
T
E
OF
RESOUREES
1
9
0
D) H
I
N
DRAN
E
E
OF
PHANN
AE
E
U
TIEAL
INNOVATION 1
9
2
2.
C
ONEEMS
AB
OUT
T
H
E
NOVELTY REQUIR
E
MENTS 1
94
A) L
A
N
GUAGE D
EPE
NDENT
PRIOR
AN
DISC10SURE PROB
L
E
M
194
B)
REN
D
E
RING IN
VEN
T
I
VE
S
TEP R
EQ
UIREMEN
T
RNE
ANINGLE
SS
196
E)
P
OTENTIAL
EONCEMS
OF
"
DIREC
T
AND
UNAMB
IG
UOU
S
"
D
ISCLO
S
UR
E
REQUI
R
E
M
ENT
19
B. IMPLIEATIONS
CONSIDERING
TBE BREADTH
OF
SE
LEETION
P
ATENTS
19
I.
SC
OPE
OFTH
E
P
ROTEETION
199
2.
SCOPE
OF
SELECTION
PATENTS
20_
A) SPECIES
S
E
L
EET
ION PATENTS
B)
O
P
T
IEAL ISOMERS
203
C)
ME
TAB
OLI
TE
D)
POLYMORPHS
3
.
ANALY
S
IS
AND CONC1USION
10
INHALT
SVER
ZE
I
CHNIS
171
-PLI
C
ATIO
LLS
CONSIDERING THE
LE
N
G
TH
O
F SELECTIOLL P
A
TENT
S
210
171
PATE
N
T
T
ENN
AUD PATENT
T
ER
M
EXTE
NSION
211
175
~,
.
A)
IN
EURO
PE 2
1
2
':
-
ARIO
N
175
)
IN TH
E
UN
ITED STA
TE
S
213
1
76
)
IN
KO
REA
2
14
L
RE
QUIREMENTS
177
PA
L
E
N
T
T
ER
M
EXTE
NS
ION ON SELECTION
P
A
TEN
TS 215
178
A)
SPE
CI
ES
SE
L
E
CTION PATENTS 215
178
B)
OP
TIC
A
L ISOM
E
RS 215
179
C) P
OL
Y ILLORP
H
S
218
180
D)
'VTETA
BOLITE 218
180
ANA
LY
SIS
AN
D CONCLUSION 218
MPLI
CATI
O
NS
O
N T
HE
COM
P
E
T
ITIO
N IN THE
P
HANNACEUTICAL INDUSTRY 222
INTRO
D
U
CTIO
N
222
QUAS
I-O
B
S
TACLES
OF
G
E
N
E
RI
CS MARKET
ENTRY 225
184
A)
SCOPE
O
F
SEC
O
ND
G
E
NERATION PATENTS 225
1
8
5
B)
LEN
G
T
H
OF
S
ECOND GEN
ERA
TI
ON
P
ATENTS
2
27
LI'.'
185
DE
L
A
Y
E
D
FIL
ING O
F
SE
C
ON
D
GENERATION
PAT
ENT
APPLICATIONS 22
7
185
REA
L
OBSTACLES
TO GE
N
ER
I
E
S'
MA
R
KET
EUTRY 229
-
'~
:E
D
UNCE
R
TAINTIES
A)
A
UT
O
M
AT
IE
THI
RTY-M
O
NT
H
S
TAY AN
D
NEW LIST
U
P
I
N T
HE
O
RANGE
BOOK
I
N
T
H
E
U
N
ITE
D
STA
TES 229
19
0
PE
N
DE
N
CY
O
F
PA
TE
NT APPLIEATIONS
:
UNCERTAINTY 231
1
92
(
1
)
PE
N
DENC
Y O
F
P
AT
E
NT A
P
P
LIEATIONS 231
194
2
)
FILING
O
F D
IVIS
I
O
N
A
L
A
PP
LIEATIONS 232
194
C)
AC
TIV
E
M
O
V
E
MENT
OF
TH
E
MAR
KE
T TO NEW
PRODUCTS
23
7
PROB
L
EM
IN
G
J
ESS
19
6
D)
A
LO
NG
WIT
B
VE
RY
SP
ECIFIC
P
A
TENT
S
ON THE
SECONDARY
PRODUCTS 240
;"
D
IS
CLO
S
URE
-
ANA
LYS
I
S
AND
CON
CLU
S
ION 242
187
198
-
UMM
AR
Y
AND
EONC1
U
S
ION
2
43
PALE
.
N!S
198
PRO
P
OSALS
245
1
99
203
LNRR
ODU
CTION 247
203
B.
N
A
TURE
OF
SE
LEETION INVENTIONS 249
203
1.
DI
F
F
EREN
T
N
A
RM
ES
OF
SEJE
ETI
ON INVENTIONS 249
206
A)
SPEEIES
SELEETION
INVE
NT
ION 249
20
8
B)
O
THER
SE
LEETION IN
V
E
NTIONS 251
2
09
2.
S
E
LEETION
IN
VE
N
TIONS FROM THE ERA
OF
PEN
IC
IL
LIN TO THE 2 HH
CENTURY 251
A) E
A
RLY MEDICATION
S A
ND
THE NOVELTY REQUIREMENT 251
11
IN
H
ALTS
\
'E
R:::
EI
C
H
'
I
IS
B
)
"MA
DE AVAILABJE TO THE PUBLIC
"
FOR THE FIR
ST
T
IME 252
3.
A
N
ALY
SI
S
UND CONCLUSION 254
C.
PROPOSAL
S
ON THE BR
E
ADTH
OF
PATENTS
25
5
1.
ARGUMENTS ON THE BREADTH
OF
PA
T
E
NTS
2
55
A)
ARGU
MEN
TS
FOR A
BROADER
PATENT
SCO
P
E
256
B)
ARGWNENTS
AGAIN
ST
A
BROADE
R
PATENT SCOP
E
2
58
C) ARGU
MENT
S
ON
PATENT
S
COPE WITH CONSIDERATION
OF
OTHER
R
E
LE
VANT FACTORS 260
2.
IN
T
ER
I
M
CON
C
LU
S
ION
26
1
3.
SOLUTION
S TO
THE OVERLAP
PI
NG
S
C
OPE
WITH
S
P
EC
I
ES SE
LE
CTIO
N
INVENTION 264
A)
VOLUNTARY IICENSING AG
RE
E
MENTS
265
B)
NO
N-VOLUNTAL)' IICENSES
2
66
(1)
COMPULSORY
LICEN
SES
267
(2)
CASE
LAW
RELEVANT
TO
COMPULSORY LICEN
SES
269
C)
REVERSE
DOCTRINE
OF
EQUIVALENTS
272
D)
C
ONCLUSION 274
D.
PROPOSALS ON THE LENGTH
OFPATENTS
275
1.
ARGUMENTS ON THE LENGTH
OF
PA
T
E
N
TS
275
2.
P
ROPOSALS
ON THE LEN
GT
H
OF
PA
TE
NTS
277
A)
PROPOSAL ON THE LENGTH
OF
BASIC PAT
EN
T
S
277
(I)
LN
T.R
ODUCTION 277
(2) P
R
OPOSED
TENN
OF
BASI
C
PATENTS 278
(3)
THE BASIS
OF
THE PROPOSAL
279
(4) E
X
P
ECTED EFFECTS
281
B) PROPOSAL
ON
THE PATENT
TENN
EXTENSION
OF
SECOND
GENERATION
PATENTS 282
E
.
PROPOSALS
ON THE PATENTABILITY
REQUIREMENTS
283
1.
LNTRODUCTION
:
TECHNOLOGY
SPE
CIFIC PATENTABILITY
STANDA
R
DS
283
2.
PROPOSALS ON THE NOV
ELT
Y
RE
Q
UIREMENT 286
A)
ARGUMENTS ON THE NOVELTY REQUIREMENT 286
B) PROPOSAL ON THE NOVELTY REQUIR
E
MENT
OF
SPECIES SELECTION
INVENTION 287
(1)
MEANING
OF
SOMETHING
"
MA
DE
AVAILA
BLE
T
O THE PUBLIC"
IN
THE PHANNACEUTICAL INDUSTL)' 287
(2) A PATENT
AS
A DOU
BLE
-EDGED SWORD
TO
NM
ES 289
12
INHALT
SVE
RZ
E
ICHNIS
252
(3) STATUTOL
"
Y EXC
EP
T
I
ONS TO T
H
E
NOV
E
LTY
R
E
QUIREMENT
AND
254
CONSI
D
E
R
ATIO
NS
T
H
ERE
OF
2
90
(4) PROPOSED NOVELTY
RE
Q
UIRE
MENT
FOR
NMES
291
255
(5)
APP
R
ECIATION
OF
THE OLANZAPI
NE
DECISI
ON AND ITS
255
E
XP
E
CTED RESULTS 293
256
C)
DI
SC
U
S
S
ION ON THE NOVELTY REQ
U
IREMENT
OF
OTHER
SELECTION
258
INVEN
TI
ONS
2
94
-
N
OFO
TH
ER
3.
PROPOSAL
S O
N THE INVENTIVE ST
EP
REQ
U
IRE
M
ENT
2
94
260
A
)
A
R
GUM
E
NT
S
ON
T
HE I
NVENTIV
E
STEP R
EQ
U
IREMENT 295
261
CL)
AR
G
UMEN
T
S
FO
R
A
ST
RICT INVENTIVE ST
E
P
RE
QUIREMENT 295
E~
,
.
ELEC
T
I
O
N
(2)
ARG
UMENTS FOR A
S
TRIC
T
INVE
N
TI
VE STEP REQUIREMENT
264
TOG
E
THER WITH
BRO
A
D
ER
PRO
TECTION 296
265
(3
)
A
RG
U
M
EN
TS
A
GAINST A STRICT INVENTI
VE
ST
EP
REQUI
REME
NT
297
266
(
4)
A
R
G
U
MEN
TS F
OR THE RELAXED IN
V
ENTIVE
S
TEP
REQUIREMENT
26
7
IN RISKY
A
N
D
EXPENSIVE
R&
D
FI
E
L
DS
297
269
B) P
RO
POSAL
ON
T
H
E
INVENTIV
E
STEP
OF
SPECI
E
S SE
LECTION
272
IN
VE
NTIONS 299
274
C)
PRO
PO
S
A
L
O
N TBE
IN
V
ENTI
VE
STE
P
OF
OTHE
R
SEL
EC
TION
INVENTIONS
300
2
7
5
(1)
J
N
TROD
UCTI
ON
300
27
5
(
2)
P
ROPOSED
S
T
A
NDARD TO A
S
SE
S
S
THE INVENTI
V
E
S
T
EP
301
277
(
3)
B
AS
I
S
OF
T
HE
P
ROPOSAL 301
277
(4
)
EXPE
CTE
D E
F
FE
CTS 304
277
4.
DISCL
LSS
ION
S
ON T
H
E
SU
FFIC
IENCY REQUIREMENT
306
278
A)
D
I
S
C
REP
A
N
CY
B
E
TW
EE
N THE SCOP
E O
F A
ND
TH
E DISCLOSURE
OF
A
2
7
9
GEN
U
S
CL
AIM
306
2
8
1
B) STRIN
G
EN
T DI
S
CLOSURE REQ,UIREMENT
OF
T
BE
B
ASIC INVENTION 307
ND
GE
N
E
R
ATION
C
)
CONC1USION
309
282
F.
CONCL
U
S
ION
309
283
TANDAR
D
S
283
VI
I.
FTNAL CONCL
U
S
IO
N
S
312
286
L
I
S
T
OF
STATUTORY
IN
STRUMENTS 321
286
LES
SE
L
EC
UEON
LIST
OF
CASE LAWS
323
287
~
LE
10
T
H
E
P
UBLI
C
"
BIBLIOGRAPHY
333
28
7
2
89
13 |
| any_adam_object | 1 |
| author | Ahn, Hyewon |
| author_GND | (DE-588)1052960936 |
| author_facet | Ahn, Hyewon |
| author_role | aut |
| author_sort | Ahn, Hyewon |
| author_variant | h a ha |
| building | Verbundindex |
| bvnumber | BV041731244 |
| classification_rvk | PU 1547 |
| collection | ZDB-18-NEA |
| ctrlnum | (OCoLC)870542522 (DE-599)DNB1047120224 |
| dewey-full | 340 346.0486 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 340 - Law 346 - Private law |
| dewey-raw | 340 346.0486 |
| dewey-search | 340 346.0486 |
| dewey-sort | 3340 |
| dewey-tens | 340 - Law |
| discipline | Rechtswissenschaft |
| doi_str_mv | 10.5771/9783845250861 |
| edition | 1. ed. |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a22000008cb4500</leader><controlfield tag="001">BV041731244</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20240528</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">140312s2014 gw m||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">14,N07</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1047120224</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783848708741</subfield><subfield code="c">Pb. : ca. EUR 89.00 (DE), ca. EUR 91.50 (AT), ca. sfr 125.00 (freier Pr.)</subfield><subfield code="9">978-3-8487-0874-1</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783848708741</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)870542522</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1047120224</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BW</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield><subfield code="a">DE-384</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-29T</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-859</subfield><subfield code="a">DE-521</subfield><subfield code="a">DE-634</subfield><subfield code="a">DE-1051</subfield><subfield code="a">DE-706</subfield><subfield code="a">DE-1046</subfield><subfield code="a">DE-860</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">340</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">346.0486</subfield><subfield code="2">22/ger</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PU 1547</subfield><subfield code="0">(DE-625)139927:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">340</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ahn, Hyewon</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1052960936</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Second generation patents in pharmaceutical innovation</subfield><subfield code="c">Hyewon Ahn</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Baden-Baden</subfield><subfield code="b">Nomos</subfield><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">354 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">MIPLC Studies</subfield><subfield code="v">19</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Universität Augsburg</subfield><subfield code="d">2013</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Patentrecht</subfield><subfield code="0">(DE-588)4044884-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Medizinprodukt</subfield><subfield code="0">(DE-588)4024018-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Medizinprodukt</subfield><subfield code="0">(DE-588)4024018-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Patentrecht</subfield><subfield code="0">(DE-588)4044884-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-3-8452-5086-1</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">MIPLC Studies</subfield><subfield code="v">19</subfield><subfield code="w">(DE-604)BV035044599</subfield><subfield code="9">19</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://doi.org/10.5771/9783845250861</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">SWB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027178023&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-18-NEA</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV041731244 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-20T05:20:46Z |
| institution | BVB |
| isbn | 9783848708741 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027178023 |
| oclc_num | 870542522 |
| open_access_boolean | 1 |
| owner | DE-M382 DE-384 DE-19 DE-BY-UBM DE-29T DE-355 DE-BY-UBR DE-473 DE-BY-UBG DE-859 DE-521 DE-634 DE-1051 DE-706 DE-1046 DE-860 |
| owner_facet | DE-M382 DE-384 DE-19 DE-BY-UBM DE-29T DE-355 DE-BY-UBR DE-473 DE-BY-UBG DE-859 DE-521 DE-634 DE-1051 DE-706 DE-1046 DE-860 |
| physical | 354 S. |
| psigel | ZDB-18-NEA |
| publishDate | 2014 |
| publishDateSearch | 2014 |
| publishDateSort | 2014 |
| publisher | Nomos |
| record_format | marc |
| series | MIPLC Studies |
| series2 | MIPLC Studies |
| spelling | Ahn, Hyewon Verfasser (DE-588)1052960936 aut Second generation patents in pharmaceutical innovation Hyewon Ahn 1. ed. Baden-Baden Nomos 2014 354 S. txt rdacontent n rdamedia nc rdacarrier MIPLC Studies 19 Dissertation Universität Augsburg 2013 Patentrecht (DE-588)4044884-8 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf Medizinprodukt (DE-588)4024018-6 gnd rswk-swf (DE-588)4113937-9 Hochschulschrift gnd-content Pharmazeutische Industrie (DE-588)4045696-1 s Arzneimittel (DE-588)4003115-9 s Medizinprodukt (DE-588)4024018-6 s Patentrecht (DE-588)4044884-8 s DE-604 Erscheint auch als Online-Ausgabe 978-3-8452-5086-1 MIPLC Studies 19 (DE-604)BV035044599 19 http://doi.org/10.5771/9783845250861 Verlag kostenfrei Volltext SWB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027178023&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Ahn, Hyewon Second generation patents in pharmaceutical innovation MIPLC Studies Patentrecht (DE-588)4044884-8 gnd Arzneimittel (DE-588)4003115-9 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd Medizinprodukt (DE-588)4024018-6 gnd |
| subject_GND | (DE-588)4044884-8 (DE-588)4003115-9 (DE-588)4045696-1 (DE-588)4024018-6 (DE-588)4113937-9 |
| title | Second generation patents in pharmaceutical innovation |
| title_auth | Second generation patents in pharmaceutical innovation |
| title_exact_search | Second generation patents in pharmaceutical innovation |
| title_full | Second generation patents in pharmaceutical innovation Hyewon Ahn |
| title_fullStr | Second generation patents in pharmaceutical innovation Hyewon Ahn |
| title_full_unstemmed | Second generation patents in pharmaceutical innovation Hyewon Ahn |
| title_short | Second generation patents in pharmaceutical innovation |
| title_sort | second generation patents in pharmaceutical innovation |
| topic | Patentrecht (DE-588)4044884-8 gnd Arzneimittel (DE-588)4003115-9 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd Medizinprodukt (DE-588)4024018-6 gnd |
| topic_facet | Patentrecht Arzneimittel Pharmazeutische Industrie Medizinprodukt Hochschulschrift |
| url | http://doi.org/10.5771/9783845250861 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027178023&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV035044599 |
| work_keys_str_mv | AT ahnhyewon secondgenerationpatentsinpharmaceuticalinnovation |